檢索結果 - Xiaoyan Si
- Showing 1 - 6 results of 6
-
1
-
2
-
3
-
4
-
5
Management of anlotinib‐related adverse events in patients with advanced non‐small cell lung cancer: Experiences in ALTER‐0303 由 Xiaoyan Si, Li Zhang, Hanping Wang, Xiaotong Zhang, Mengzhao Wang, Baohui Han, Kai Li, Qiming Wang, Jianhua Shi, Zhehai Wang, Ying Cheng, Yuankai Shi, Weiqiang Chen, Xiuwen Wang, Yi Luo, Kejun Nan, Faguang Jin
出版 2019Artigo -
6
Single-cell profiling identifies IL1Bhi macrophages associated with inflammation in PD-1 inhibitor-induced inflammatory arthritis 由 Ziyue Zhou, Xiaoxiang Zhou, Xu Jiang, Bo Yang, Xin Lu, Yunyun Fei, Lidan Zhao, Hua Chen, Li Zhang, Xiaoyan Si, Naixin Liang, Yadong Wang, Dan Yang, Yezi Peng, Yiying Yang, Zhuoran Yao, Yangzhige He, Xunyao Wu, Wen Zhang, Min Wang, Huaxia Yang, Xuan Zhang
出版 2024Artigo
相關主題
Medicine
Immunology
Internal medicine
Adverse effect
Immune system
Biochemistry
Chemistry
Disease
Immunotherapy
Oncology
16S ribosomal RNA
Alternative medicine
Anemia
Aplastic anemia
Arthritis
Autoimmune hemolytic anemia
Biomarker
Bone marrow
CD8
CXCL10
Cancer
Cancer research
Chemokine
Chemotherapy
Common Terminology Criteria for Adverse Events
Cytopenia
Cytotoxic T cell
Firmicutes
Gene
Gut flora